-
1
-
-
0036252989
-
B cell diversity and longevity in systemic autoimmunity
-
Zouali M (2002) B cell diversity and longevity in systemic autoimmunity. Mol Immunol 38, 895-901.
-
(2002)
Mol Immunol
, vol.38
, pp. 895-901
-
-
Zouali, M.1
-
2
-
-
0035118621
-
Treatment of systemic lupus erythematosus with LJP 394
-
Furie RA, Cash JM, Cronin ME et al. (2001) Treatment of systemic lupus erythematosus with LJP 394. J Rheumatol 28, 257-65.
-
(2001)
J Rheumatol
, vol.28
, pp. 257-265
-
-
Furie, R.A.1
Cash, J.M.2
Cronin, M.E.3
-
3
-
-
0037331980
-
LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double-blind, placebo-controlled study
-
Alarcon-Segovia D, Tumlin JA, Furie RA et al. (2003) LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study. Arthritis Rheum 48, 442-54.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 442-454
-
-
Alarcon-Segovia, D.1
Tumlin, J.A.2
Furie, R.A.3
-
4
-
-
0242495115
-
Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B Lymphocyte stimulation
-
Baker K, Edwards BM, Main SH et al. (2003) Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B Lymphocyte stimulation. Arthritis Rheum 48, 3253-65.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 3253-3265
-
-
Baker, K.1
Edwards, B.M.2
Main, S.H.3
-
5
-
-
0035167632
-
Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus
-
Zhang J, Roschke V, Baker K et al. (2001) Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 166, 6-10.
-
(2001)
J Immunol
, vol.166
, pp. 6-10
-
-
Zhang, J.1
Roschke, V.2
Baker, K.3
-
6
-
-
0034972257
-
Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases
-
Cheema GS, Roschke V, Hilbert DM et al. (2001) Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 44, 1313-9.
-
(2001)
Arthritis Rheum
, vol.44
, pp. 1313-1319
-
-
Cheema, G.S.1
Roschke, V.2
Hilbert, D.M.3
-
7
-
-
0347288173
-
BlyS plasma concentrations correlate with disease activity and levels of anti-dsDNA autoantibodies and immunoglobulins (IG) in a SLE observational study
-
Petri M, Stohl W, Chatham W et al. (2003) BlyS plasma concentrations correlate with disease activity and levels of anti-dsDNA autoantibodies and immunoglobulins (IG) in a SLE observational study. Arthritis Rheum 48, S655.
-
(2003)
Arthritis Rheum
, vol.48
-
-
Petri, M.1
Stohl, W.2
Chatham, W.3
-
8
-
-
1242314612
-
B lymphocyte depletion in the treatment of systemic lupus (SLE): Phase I/II trial of rituximab in SLE
-
Anolik JH, Campbell D, Felgar R et al. (2002) B lymphocyte depletion in the treatment of systemic lupus (SLE): phase I/II trial of rituximab in SLE (Abstract). Arthritis Rheum 46, S717.
-
(2002)
Arthritis Rheum
, vol.46
-
-
Anolik, J.H.1
Campbell, D.2
Felgar, R.3
-
9
-
-
0036822286
-
An open study of B cell depletion in systemic lupus erythematosus
-
Leandro MJ, Edwards JC, Cambridge G et al. (2002) An open study of B cell depletion in systemic lupus erythematosus. Arthritis Rheum 46, 2673-7.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 2673-2677
-
-
Leandro, M.J.1
Edwards, J.C.2
Cambridge, G.3
-
10
-
-
0037638841
-
Rituximab therapy and autoimmune disorders
-
Silverman GJ, Weisman S (2003) Rituximab therapy and autoimmune disorders. Arthritis Rheum 48, 1484-92.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 1484-1492
-
-
Silverman, G.J.1
Weisman, S.2
-
11
-
-
1542705891
-
B cell depletion therapy in systemic lupus erythematosus
-
Anolik J, Sanz I, Looney RJ (2003) B cell depletion therapy in systemic lupus erythematosus. Curr Rheumatol Report 5, 350-6.
-
(2003)
Curr Rheumatol Report
, vol.5
, pp. 350-356
-
-
Anolik, J.1
Sanz, I.2
Looney, R.J.3
-
12
-
-
0036899589
-
Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154
-
Kalunian KC, Davis JC, Merrill JT et al. (2002) Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154. Arthritis Rheum 46, 3251-8.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 3251-3258
-
-
Kalunian, K.C.1
Davis, J.C.2
Merrill, J.T.3
-
13
-
-
0035163042
-
Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus
-
Davis JC Jr, Totoritis MC, Rosenberg J et al. (2001) Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus. J Rheumatol 28, 95-101.
-
(2001)
J Rheumatol
, vol.28
, pp. 95-101
-
-
Davis Jr., J.C.1
Totoritis, M.C.2
Rosenberg, J.3
-
14
-
-
0034089902
-
Novel approaches to therapy for systemic lupus erythematosus
-
Zandman-Goddard G, Shoenfeld Y (2002) Novel approaches to therapy for systemic lupus erythematosus. Eur J Int Med 11, 130-4.
-
(2002)
Eur J Int Med
, vol.11
, pp. 130-134
-
-
Zandman-Goddard, G.1
Shoenfeld, Y.2
-
15
-
-
0032728801
-
A study of 20 SLE patients with intravenous immunoglobulin - Clinical and serologic response
-
Levy Y, Sherer Y, Ahmed A, Langevitz P et al. (1999) A study of 20 SLE patients with intravenous immunoglobulin - clinical and serologic response. Lupus 8, 705-12.
-
(1999)
Lupus
, vol.8
, pp. 705-712
-
-
Levy, Y.1
Sherer, Y.2
Ahmed, A.3
Langevitz, P.4
-
16
-
-
0034098474
-
Intravenous immunoglobulin treatment of lupus nephritis
-
Levy Y, Sherer Y, George J et al. (2000) Intravenous immunoglobulin treatment of lupus nephritis. Semin Arthritis Rheum 29, 321-7.
-
(2000)
Semin Arthritis Rheum
, vol.29
, pp. 321-327
-
-
Levy, Y.1
Sherer, Y.2
George, J.3
-
17
-
-
0345059308
-
Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis
-
Levy Y, Uziel Y, Zandman GG et al. (2003) Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis. Ann Rheum Dis 62, 1221-3.
-
(2003)
Ann Rheum Dis
, vol.62
, pp. 1221-1223
-
-
Levy, Y.1
Uziel, Y.2
Zandman, G.G.3
-
18
-
-
0033883903
-
Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus
-
Llorente L, Richaud-Patin Y, Garcia-Padilla C et al. (2000) Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 43, 1790-80.
-
(2000)
Arthritis Rheum
, vol.43
, pp. 1790-1880
-
-
Llorente, L.1
Richaud-Patin, Y.2
Garcia-Padilla, C.3
|